Summary of Study ST002736
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001700. The data can be accessed directly via it's Project DOI: 10.21228/M8ZM7F This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002736 |
| Study Title | Assessing mitochondrial bioenergetics in coronary artery disease: A translational multiomic tissue study in humans (The AMBITION study). |
| Study Summary | Background: Severe or recurrent myocardial ischemia can lead to chronic left ventricular (LV) dysfunction and heart failure in patients with coronary artery disease (CAD). Objectives: To assess the multiomic profile of LV myocardium in patients with stable CAD. Methods: Patients undergoing coronary artery bypass grafting (CABG) had preoperative quantitative stress perfusion cardiovascular magnetic resonance. During surgery, paired transmural LV biopsies were acquired on the beating heart from a region of inducible ischemia, and a remote LV segment. LV samples from human organ donors were used as controls. Myocardial biopsies underwent high-energy phosphate quantification, liquid chromatography-mass spectrometry and single-nuclei ribonucleic acid sequencing. Results: From 33 patients, 63 LV biopsies were acquired on the beating heart during CABG (mean age 60±9 years, median LV ejection fraction 67% [IQR: 61-71%]). Analysis of LV samples from 11 essentially healthy donor hearts were included. The global myocardial ATP/ADP ratio was reduced in CAD patients as compared to donor LV tissue (median [IQR]: 2.2 [1.5-2.8] versus 7.4 [6.8-8.6], P=0.001), with increased expression of oxidative phosphorylation (OXPHOS) genes encoding the electron transport chain complexes across multiple cell types. Paired analyses of biopsies obtained during CABG from LV segments with or without inducible ischemia revealed no significant difference in the ATP/ADP ratio (P=0.36), broader metabolic profile or expression of ventricular cardiomyocyte genes implicated in OXPHOS. Conclusions: Our results suggest that viable human myocardium in patients with stable CAD has global alterations in bioenergetic and transcriptional profile without large regional differences between areas with or without inducible ischemia. |
| Institute | Imperial College London |
| Last Name | Jones |
| First Name | Richard Elis |
| Address | Royal Brompton Hospital |
| richard.jones34@nhs.net | |
| Phone | 02073528121 |
| Submit Date | 2023-05-29 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | raw(Thermo) |
| Analysis Type Detail | LC-MS |
| Release Date | 2023-07-06 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN004438 |
|---|---|
| Analysis type | MS |
| Chromatography type | HILIC |
| Chromatography system | Thermo Dionex Ultimate 3000 |
| Column | SeQuant ZIC- pHILIC (150 x 2.1mm,5um) |
| MS Type | ESI |
| MS instrument type | Orbitrap |
| MS instrument name | Thermo Q Exactive Orbitrap |
| Ion Mode | UNSPECIFIED |
| Units | peak area |
MS:
| MS ID: | MS004185 |
| Analysis ID: | AN004438 |
| Instrument Name: | Thermo Q Exactive Orbitrap |
| Instrument Type: | Orbitrap |
| MS Type: | ESI |
| MS Comments: | Metabolites were measured using a Thermo Scientific Q Exactive Hybrid Quadrupole-Orbitrap Mass spectrometer (HRMS) coupled to a Dionex Ultimate 3000 UHPLC. The mass spectrometer was operated in full-scan, polarity-switching mode, with the spray voltage set to +4.5 kV/-3.5 kV, the heated capillary held at 320 °C, and the auxiliary gas heater kept at 280 °C. The sheath gas flow was programmed to 55 units, the auxiliary gas flow was programmed to 15 units, and the sweep gas flow was programmed to 0 unit. HRMS data acquisition was performed in a range of m/z = 70–900, with the resolution set at 70,000, the AGC target at 1 × 106, and the maximum injection time (Max IT) at 120 ms. Metabolite identities were confirmed using two parameters: (1) precursor ion m/z was matched within 5 ppm of theoretical mass predicted by the chemical formula; (2) the retention time of metabolites was within 5% of the retention time of a purified standard run with the same chromatographic method. Each sample underwent 3 analytical repeats with subsequent peak annotation and chromatogram review and peak area integration were performed using the Thermo Fisher software Tracefinder 5.0. The peak area for each detected metabolite was subjected to the “Filtering 80% Rule”, half minimum missing value imputation, and normalized against the total ion count (TIC) to correct any variations introduced from sample handling through instrument analysis. Samples were excluded after performing testing for outliers based on geometric distances of each point in the PCA score analysis as part of the muma package (v.1.4) |
| Ion Mode: | UNSPECIFIED |
